Table 1.
Primers used in the study
| Genes | Sequences (5′-3′) |
|---|---|
| BCL-2 |
F: TGTGTGTGGAGAGCGTCAAC R: GACAGCCAGGAGAAATCAAAC |
| GAPDH |
F: AGCCACATCGCTCAGACAC R: GCCCAATACGACCAAATCC |
| IL6 |
F: TACCCCCAGGAGAAGATTCC R: TTTTCTGCCAGTGCCTCTTT |
| IL-8 |
F: CTGGACCCCAAGGAAAACTG R: TTCTCAGCCCTCTTCAAAAAC |
| SVV |
F: GAACTGGCCCTTCTTGGAG R: AAGTCTGGCTCGTTCTCAGTG |
| TGFβ1 |
F: TGCTAATGGTGGAAACCCACAACG R: TCTCGGAGCTCTGATGTGTTGAAG |
| TNFA |
F: CTCCTCACCCACACCATCAG R: GGAAGACCCCTCCCAGATAG |
| VEGF |
F: GTGATGATTCTGCCCTCCTC R: CCTTGCTGCTCTACCTCCAC |
BCL-2 B-cell lymphoma 2, GAPDH glyceraldehyde 3-phosphate dehydrogenase, IL6 interleukin 6, IL8 interleukin 8, SVV survivin, TGFβ1 transforming growth factor β1, TNFA tumor necrosis factor α, VEGF vascular endothelial growth factor